Progress in Type 2 Diabetes Care

image
DPP-4: The Physiology of Incretin Degradation
The enzymatic degradation of GLP-1 and GIP is the primary, but not the only, function of DPP-4.
image
Incretins and More: The Physiology of DPP-4
Type 2 diabetes in youth has increased significantly in recent years. Here’s a breakdown.
image
New Approaches for DKD in Adolescents with T2D
Youth-onset T2D carries a higher risk of diabetic kidney disease than both adult-onset T2D of similar duration and T1D. Is there a path to prevention and slowing progression?
image
How Effective is Weight Loss as Therapy for Type 2 Diabetes?
Yale obesity expert Ania Jastreboff, MD, PhD, describes the promise and limits of weight loss as a means of controlling T2D.
image
T2D In Youth
Here’s a snapshot of the changing face of type 2 diabetes in children and youth.
image
Potential Risks of Anti-obesity Medications in Patients with T2D
Obesity and diabetes specialist Ania Jastreboff, MD, PhD, of Yale, describes how to reduce the potential risks of weight-loss medications in patients also being treated with T2D medications.